Skip to main content
. 2021 May 28;96(4):458–471. doi: 10.1016/j.abd.2020.12.007

Table 1.

Classification of T-cell lymphomas with primary cutaneous manifestations according to their clinical behavior, frequency and disease-specific 5-year survival. Based on the WHO-EORTC guidelines.1

Clinical behavior Frequency (%) Disease-specific 5-year survival (%)
Mycosis fungoides Indolent 39 88
Mycosis fungoides variants
Folliculotropic mycosis fungoides Indolent 5 75
Pagetoid reticulosis Indolent <1 100
Granulomatous slack skin Indolent <1 100
Sézary syndrome Aggressive 2 36
Primary Cutaneous CD30+ Lymphoproliferative Disorders
Primary cutaneous anaplastic large T-cell lymphoma Indolent 8 95
Lymphomatoid papulosis Indolent 12 99
Adult T-cell lymphoma/leukemia Indolent / Aggressive <1 NR
Subcutaneous panniculitis-like T-cell lymphoma Indolent 1 87
Extranodal NK/T-cell lymphoma, nasal type Aggressive <1 16
Chronic active EBV infection Indolent <1 NR
Primary cutaneous T-cell lymphoma γ/δ Aggressive <1 11
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma Aggressive <1 31
Primary cutaneous acral CD8+ T-cell lymphoma Indolent <1 100
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder Indolent 6 100
Primary Cutaneous Peripheral T-Cell Lymphoma, NOS Aggressive 2 15

NR, not reported; NOS, not otherwise specified.